PISCATAWAY, N.J. – Camber Pharmaceuticals announces the addition of atazanavir capsules to their current portfolio.
Atazanavir capsules are indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and in pediatric patients 6 years and older weighing at least 33 lbs.
Atazanavir capsules from Camber are available in 150 mg and 200 mg- 60 count bottles and 300 mg- 30 count bottle.
Comments are closed.